NO20043112L - Peptider egnet for behandling av human papillomavirus (HPV)-assosiert kreft og andre epiteliale tumorer - Google Patents

Peptider egnet for behandling av human papillomavirus (HPV)-assosiert kreft og andre epiteliale tumorer

Info

Publication number
NO20043112L
NO20043112L NO20043112A NO20043112A NO20043112L NO 20043112 L NO20043112 L NO 20043112L NO 20043112 A NO20043112 A NO 20043112A NO 20043112 A NO20043112 A NO 20043112A NO 20043112 L NO20043112 L NO 20043112L
Authority
NO
Norway
Prior art keywords
hpv
treatment
human papillomavirus
associated cancer
epithelial tumors
Prior art date
Application number
NO20043112A
Other languages
English (en)
Other versions
NO333259B1 (no
Inventor
Osvaldo Reyes Acosta
Silvio Ernesto Perea Rodriguez
Nelson Francisco Santiag Vispo
Yaquelin Puchades Lzaguirre
Ricardo Silva Rodriguez
Alejandro Moro Soria
Alicia Santos Savio
Luis Javier Gonzalez Lopez
Belkis Gonzalez Barrios
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of NO20043112L publication Critical patent/NO20043112L/no
Publication of NO333259B1 publication Critical patent/NO333259B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20043112A 2001-12-20 2004-07-20 Peptider som inhiberer Casein Kinase II fosforyleringssete og som kan anvendes for fremstilling av medikamenter til inhibering av tumorcelle-proliferasjon, samt DNA ekspresjonsvektorer som koder for slike peptider NO333259B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20010309A CU23225A1 (es) 2001-12-20 2001-12-20 PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
PCT/CU2002/000010 WO2003054002A1 (es) 2001-12-20 2002-12-04 Péptidos para el tratamiento del cáncer asociado al virus papiloma humano (vph) y de otros tumores epiteliales

Publications (2)

Publication Number Publication Date
NO20043112L true NO20043112L (no) 2004-07-20
NO333259B1 NO333259B1 (no) 2013-04-22

Family

ID=40091679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043112A NO333259B1 (no) 2001-12-20 2004-07-20 Peptider som inhiberer Casein Kinase II fosforyleringssete og som kan anvendes for fremstilling av medikamenter til inhibering av tumorcelle-proliferasjon, samt DNA ekspresjonsvektorer som koder for slike peptider

Country Status (33)

Country Link
US (2) US7374767B2 (no)
EP (2) EP2383282A1 (no)
JP (1) JP4056476B2 (no)
KR (1) KR100642437B1 (no)
CN (1) CN100368431C (no)
AR (1) AR037825A1 (no)
AT (1) ATE520704T1 (no)
AU (1) AU2002361922B2 (no)
BR (1) BRPI0215213C1 (no)
CA (1) CA2471110C (no)
CR (1) CR7361A (no)
CU (1) CU23225A1 (no)
DK (1) DK1491553T3 (no)
DO (1) DOP2002000548A (no)
ES (1) ES2371239T3 (no)
HN (1) HN2002000377A (no)
HR (1) HRP20040663B1 (no)
IL (2) IL162633A0 (no)
IS (1) IS2906B (no)
MA (1) MA27868A1 (no)
MX (1) MXPA04005832A (no)
MY (1) MY133530A (no)
NO (1) NO333259B1 (no)
NZ (1) NZ534170A (no)
PE (1) PE20030861A1 (no)
PT (1) PT1491553E (no)
RU (1) RU2290410C2 (no)
SI (1) SI1491553T1 (no)
TN (1) TNSN04114A1 (no)
UA (1) UA81403C2 (no)
UY (1) UY27602A1 (no)
WO (1) WO2003054002A1 (no)
ZA (1) ZA200405514B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
CU23431B6 (es) * 2005-05-12 2009-10-16 Ct Ingenieria Genetica Biotech Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
GB2433740A (en) * 2005-12-23 2007-07-04 Rapid Biosensor Systems Ltd Detection of tuberculosis infection
CU23511B6 (es) 2006-02-28 2010-04-13 Biorec B V Combinación farmacéutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
CN100522992C (zh) * 2007-02-12 2009-08-05 中国科学院昆明动物研究所 一种环状小肽ba
WO2008117767A1 (ja) 2007-03-27 2008-10-02 Taiko Pharmaceutical Co., Ltd. 感染性皮膚および粘膜疾患治療薬
WO2010096751A1 (en) 2009-02-23 2010-08-26 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating a disease mediated by soluble oligomeric amyloid beta
US8569065B2 (en) * 2009-03-13 2013-10-29 Egen, Inc. Compositions and methods for the delivery of biologically active RNAs
KR20250057128A (ko) 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
CU20200103A7 (es) * 2020-12-18 2022-07-08 Ct Ingenieria Genetica Biotecnologia Péptido sintético para la inducción de inmunidad antitumoral y antiviral
CU24766B1 (es) 2021-07-09 2025-08-13 Ct Ingenieria Genetica Biotecnologia Péptidos lineales que inhiben la fosforilación mediada por ck2
CN118370805B (zh) * 2024-04-29 2025-02-14 广州中科佰氏健康产业有限公司 一种抑菌妇科凝胶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902820A1 (en) * 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
EP0531080A3 (en) * 1991-09-04 1993-12-29 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein
GB9313556D0 (en) * 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
EP0969013B1 (en) * 1998-06-30 2003-03-26 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Peptides for inhibiting HPV E7 proteins
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
US6641994B2 (en) * 1999-08-25 2003-11-04 Pharmacia & Upjohn Company Methods of identifying anti-viral agents
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Also Published As

Publication number Publication date
MXPA04005832A (es) 2004-09-13
MA27868A1 (fr) 2006-05-02
PT1491553E (pt) 2011-11-25
PE20030861A1 (es) 2003-12-02
SI1491553T1 (sl) 2011-12-30
MY133530A (en) 2007-11-30
DK1491553T3 (da) 2011-12-05
US7374767B2 (en) 2008-05-20
JP2005525090A (ja) 2005-08-25
US7947287B2 (en) 2011-05-24
CU23225A1 (es) 2007-08-30
KR20050002811A (ko) 2005-01-10
DOP2002000548A (es) 2003-06-30
KR100642437B1 (ko) 2006-11-06
IL162633A (en) 2011-02-28
BRPI0215213B1 (pt) 2018-09-11
CR7361A (es) 2005-02-18
EP2383282A1 (en) 2011-11-02
UA81403C2 (en) 2008-01-10
RU2004122084A (ru) 2005-03-27
HRP20040663B1 (hr) 2013-05-31
TNSN04114A1 (en) 2006-06-01
CA2471110A1 (en) 2003-07-03
AU2002361922B2 (en) 2007-04-05
RU2290410C2 (ru) 2006-12-27
EP1491553B1 (en) 2011-08-17
IS2906B (is) 2014-11-15
IL162633A0 (no) 2005-11-20
BRPI0215213C1 (pt) 2021-05-25
CA2471110C (en) 2017-01-31
HN2002000377A (es) 2003-04-10
AR037825A1 (es) 2004-12-09
IS7320A (is) 2004-06-16
US20060233742A1 (en) 2006-10-19
WO2003054002A1 (es) 2003-07-03
CN1620464A (zh) 2005-05-25
JP4056476B2 (ja) 2008-03-05
CN100368431C (zh) 2008-02-13
ZA200405514B (en) 2005-03-30
NO333259B1 (no) 2013-04-22
HK1068901A1 (en) 2005-05-06
EP1491553A1 (en) 2004-12-29
ES2371239T3 (es) 2011-12-28
UY27602A1 (es) 2003-04-30
BR0215213A (pt) 2004-12-07
HRP20040663A2 (en) 2005-08-31
ATE520704T1 (de) 2011-09-15
AU2002361922A1 (en) 2003-07-09
NZ534170A (en) 2006-08-31
US20090005294A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
NO2012016I2 (no) Kombinasjon av HPV16 og HPV18 L1 viruslignende partikler
NO20033883L (no) Heterosykliske derivater for behandling av kreft og andre proliferative sykdommer
AU2002327338A1 (en) Use of glycosylceramides as adjuvants for vaccines against infections and cancer
IL200404A (en) Conjugates of antibodies that bind 191p4d12(b)proteins and uses thereof for treating cancer
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
EP1446121A4 (en) DI-INDOLYLMETHANE FOR THE TREATMENT OF INFECTIONS BY HUMAN PAPILLOMAVIRUS
ATE414512T1 (de) Kombinationstherapie zur behandlung von krebs
DK1491553T3 (da) Peptider til behandling af cancer forbundet med human papillomavirus (HPV) og andre epitheliale tumorer
WO2004104039A8 (en) Tumor antigens for prevention and/or treatment of cancer
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002327639A1 (en) Detection and treatment of cancers of breast
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002251367A1 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AU2002342858A1 (en) Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
AU2002306952A1 (en) Detection and treatment of colorectal cancer
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
AU2002251286A1 (en) Diagnosis and treatment of cancer:ii
WO2004005463A9 (en) Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
AU2002234617A1 (en) Cosmetic or pharmaceutical preparations of the treatment of epithelial outer tissue

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees